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Summary objectives To study trends in Zambia’s TB notification rates between 1990 and 2010 and to ascertain
progress made towards TB control.
methods Retrospective review of TB notification returns and TB programme reports for the period
from 1990 to 2010.
results Two distinct TB trend periods were identified: a period of rising trends up to a peak between
1990 and 2004 and a period of moderately declining trends between 2004 and 2010. Treatment out-
comes improved over the two decades. Data on trends in paediatric TB, TB in prisoners and TB in
pregnant women remain scanty and unreliable owing to poor diagnostic capability. There were no data
available on trends on drug-resistant TB because of the lack of laboratory services to perform drug
sensitivity testing.
conclusions The period of increasing TB between 1990 and 2000 coincided with an increase in
HIV ⁄AIDS. The period of slightly decreasing TB between 2004 and 2010 can be attributed to improved
TB care, sustained DOTS implementation and improvement in TB diagnostic services. Newer diag-
nostics technologies for the rapid diagnosis of active TB cases and for drug-resistant testing, recently
endorsed by the WHO, need to be implemented into the national TB programmes to detect more cases
and to provide epidemiological and surveillance data from which to obtain an evidence base for guided
investments for TB control. Alignment of TB and HIV services is required to achieve improved
management outcomes.
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Introduction
WHO declared tuberculosis (TB) a global emergency in
1993 and recommended directly observed treatment short
course (DOTS) in 1995 as a cost-effective strategy for TB
control worldwide (WHO 1995). However, TB remains a
major public health problem (WHO 2010a). The global
burden of TB in 2009 was estimated to be approximately
9.4 million incident cases (equivalent to 137 cases per
100 000 population) and 1.7 million people died of TB.
Women accounted for 35% of all cases (WHO 2010a).
Approximately 80% of the TB cases notified worldwide
were from the 22 high-burden countries (HBCs), and
WHO concentrates mainly on these HBCs to show
progress and programme performance.
In Zambia, a country with a population of 13 million
people, TB continues to be among the big public health
problems (Mulenga et al. 2010b), more than 40 years
after launching the TB ⁄Leprosy National Control
Programme (NTP) (Bosman 2000). The burden of the
disease is exacerbated by the high prevalence of
HIV ⁄AIDS, estimated to be approximately 13.5%
(UNAIDS 2010); by widespread poverty (CSO 2011b);
and by inadequate control strategies in congregate
settings such as prisons that act as reservoirs for the
disease (Todrys 2010; O’Grady et al. 2011a,b). However,
Zambia is not currently listed as one of the 22 HBCs,
presumably owing to its relatively small population, and
does not receive the same support as the HBCs for TB
control.
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No TB data were reported to WHO from Zambia for the
years 1997–1999 owing to the almost complete collapse
of the NTP during healthcare reforms when vertical
programmes were abolished and integrated with general
health services (Bosman 2000; Mwaba et al. 2003). During
this period, the TB burden in Zambia was as high as in
some neighbouring countries included in the HBC group,
such as Zimbabwe. It is possible that the non-reporting
period may have resulted in Zambia not being identified as
one of the HBCs (Mwaba et al. 2003).
TB diagnosis in Zambia is mainly through microscopy;
the country has 158 diagnostic facilities and 1800 treat-
ment facilities. Childhood TB data are not adequately
captured because of problems with diagnosis and report-
ing; thus, available data may not reflect the true burden
(Marais et al. 2006). Data on drug-resistant TB are not
routinely collected by the NTP, and the burden of multiple
drug-resistant TB (MDR-TB – Mycobacterium tuberculosis
resistant to at least rifampicin and isoniazid) is estimated
to be 1.8% of new TB cases by WHO (2010a). Approx-
imately 67% of TB patients notified to the NTP are
co-infected with HIV (CDC 2008, WHO 2010a).
In order to study trends in TB notification rates and to
ascertain progress made towards TB control, we conducted
a retrospective study looking at the period from 1990 to
2010. We discuss potential factors that have contributed to
the changes in TB disease profile in the past decade, and
make recommendations on improving current TB diag-
nostic services, drug resistance surveillance and recording
and reporting of data that are important for achieving
TB control in Zambia.
Methods
A retrospective review and analysis of routine National TB
surveillance data was performed using available data from
1990 to 2010. The data reviewed included all age groups
and both genders; it was analysed in terms of aggregated
national notifications, gender profiling and annual trends.
Further desk reviews of in-country TB reports were also
conducted to assess TB programme performance. Data
available from published National TB programme review
reports and other TB programme assessment reports were
reviewed for the period 2000–2010. Case notification rates
were calculated using the estimates of population from the
central statistics office. Descriptive statistics were used to
generate trends in notifications and selected treatment
outcomes over the years. The sputum smear-negative cases
were defined according to the National TB manual as
adapted from the WHO guidelines as: ‘Tuberculosis in a
patient with three initial negative smear examinations by
direct microscopy for Acid Fast Bacilli (AFB)) and non-
response to a course of broad-spectrum antibiotics, and
again three negative sputum smear examinations by direct
microscopy, and X-ray abnormalities suggestive of active
tuberculosis as determined by the treating Medical Doc-
tor ⁄Clinician’ or ‘Tuberculosis in a patient with three
initial sputum smear examinations negative by direct
microscopy but positive by culture for mycobacterium’.
We used the Mann–Whitney U-test to assess the differences
in TB prevalence between men and women.
Results
Total notifications
Over the past two decades, between 1990 and 2010, a total
of 759 769 cases of all forms of TB were reported through
health facilities in Zambia (Table 1). The average annual
notification rate was 42 209 cases nationwide. The data
can be divided into two distinct phases: pre- and post-2004
(Figure 1). TB case notifications increased steadily from
16 863 in 1990 to a peak of 58 070 in 2004. Thereafter,
from 2004 to 2010, there has been a demonstrable decline
in the absolute number of TB notifications countrywide.
Table 1 Zambian TB case notifications and case notification rate
per 100 000 population from 1990 to 2010
Years
Total
notification Population
CNR
(per 100 000
population)
1990 16 863 7 817 803 216
1991 21 550 8 831 967 244
1992 25 448 8 235 599 309
1993 28 842 8 609 552 335
1994 33 492 8 860 317 378
1995 33 553 9 142 507 367
1996 38 863 9 501 956 409
1997 *Not available N ⁄A
1998 *Not available N ⁄A
1999 *Not available N ⁄A
2000 49 806 9 885 591 504
2001 52 757 10 089 492 523
2002 45 836 10 409 441 440
2003 55 275 10 744 380 514
2004 58 070 11 089 691 524
2005 53 569 11 441 461 468
2006 51 179 11 798 678 434
2007 50 415 12 160 516 415
2008 47 333 12 525 791 378
2009 48 510 12 896 830 376
2010 48 408 13 272 553 365
CNR, case notification rate.
*Data not available because of donor insistence on removing
the vertical programme and subsequent collapse of the TB
programme.
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The same trends are observed when the data are disag-
gregated by type of TB: sputum smear positive, smear
negative, extrapulmonary TB and retreatment positives.
There are consistently and significantly more smear-negative
TB cases reported each year than smear-positive cases.
Data from years 1997, 1998 and 1999 were not
available because of the collapse of the NTP owing to
donor advice for the integration of all health services, thus
removing the vertical NTP infrastructure. There was no
specific funding for the TB programme until the year 2000
when the programme was resuscitated and reporting
systems were re-activated.
Tuberculosis trends by gender
The trends by gender are similar to the total notifications
data (Figure 2). Generally, there are more male cases than
female cases (P = 0.035) in spite of the fact that there are
more females than males in the Zambian general popula-
tion (CSO 2011a). However, this is consistent with global
trends in TB by gender (WHO 2010a). Most of the notified
cases are in the age range of 25–44. There is a significant
difference in TB prevalence between children (<15 years)
and adults (P = 0.002).
Treatment outcomes
The cure rates almost doubled in the last decade, from
47% in 2000 to 82% in 2009 (Table 2). The treatment
default rates declined from 19% in 2000 to 4% in 2009;
consequently, the treatment success rate increased from
66% in 2000 to 86% by the year 2009. The crude death
rates from the national cohorts have also declined by more
than half from 12% in 2001 to 5% in 2009. Only sporadic
data were available from the NTP for cure rates, default
rates, treatment success rates and crude death rates
previous to 2000.
Drug-resistant TB
No routine data are collected for drug-resistant TB by the
Zambian NTP to date, although there have been cases of
drug-resistant TB diagnosed at tertiary referral centres. No
diagnosis of extensively drug-resistant TB (XDR-TB) has
been reported to the NTP.
Other data
Data on trends in paediatric TB, TB in prisoners and TB in
pregnant women were not assessable as records were not
available for these subgroups. Data on paediatric TB are
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Figure 1 Trends of TB case notification rate all forms (per
100 000 population), 1990–2010. Data not available for 1998–
2000 because of donor insistence on removing the vertical NTB
programme and integration of all health services. The NTP was
re-instated in 2000.
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Figure 2 TB notifications all forms by gender 2003–2009.
Table 2 Treatment Outcomes Among Smear-Positive Cohorts
from 2000 to 2009: Zambia
Years
Cure
rates (%)
Treatment
default
rate (%)
Treatment
success
rate (%)
Crude
death
rate (%)
2000 47 19 66 7
2001 58 16 74 12
2002 67.7 11 78.7 10
2003 72.5 9 81.5 8.5
2004 75.6 6.5 82.1 8
2005 76 8 84 7.6
2006 77 8 85 6.6
2007 78 7 85 6.4
2008 82 4 86 5
2009 82 4 86 5
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scarce and unreliable because of poor diagnostic capability
and inappropriateness of current diagnostic algorithms.
Discussion
Two distinct TB trends are seen in Zambia over the past
20 years: (i) a period of increasing TB between 1990 and
2000 which appears to have coincided with an increase in
the prevalence of HIV ⁄AIDS and (ii) a period of slightly
decreasing TB between 2004 and 2010 which could be
attributed to greater investments into the NTP by donors
and the government and sustained DOTS implementation.
However, under-reporting owing to poor record keeping is
another possible reason for the decline.
Our study shows that the TB burden in Zambia remains
high and continues to pose a serious public health
challenge in spite of the implementation of the DOTS
strategy as recommended by WHO (2010b). Whilst the
decline in TB rates over the past decade is encouraging,
more funding and investment is required for more effective
diagnostic services and drug resistance testing and for
enhancing DOTS implementation. Newer diagnostics
technologies for the rapid diagnosis of active TB cases and
for drug-resistant testing, recently endorsed by the WHO,
need to be implemented into the national TB programmes
so as to increase case detection and to provide epidemio-
logical and surveillance data from which to obtain an
evidence base for guided investments for TB control. Data
are also required for assessing trends of TB in children and
other vulnerable groups including pregnant women and
prisoners.
The WHO estimates that Zambia has a case detection
rate of approximately 80% (WHO 2010a), meaning that
approximately 12 000 TB cases go undiagnosed each year.
The public and semipublic sectors notify 90% of cases; the
remainder is from a limited number of private sector
facilities that collaborate with the NTP. There is therefore
a likely discrepancy in the number of cases notified by
the Zambia NTP and the TB cases diagnosed and treated in
the country because of the private sector facilities that do
not report to the NTP. It is unclear how many patients with
TB use the informal health sector, such as traditional
healers, in Zambia. There is a need to strengthen public–
private partnerships to capture all TB cases and to
ascertain the proportion of TB cases that the informal
sector is attending to.
TB case notifications and rates increased dramatically
from 1990 to 2004. This was a true increase because there
was no expansion of NTP activities during this time. For
3 years (1997–1999), the NTP infrastructure collapsed.
Reasons for the rise in TB during the period 1990–2004
include the growing HIV pandemic (UNAIDS 2010); the
growing population (CSO 2011a); population urbanization
leading to overcrowding and poor housing (CSO 2011a);
and higher poverty levels. Since 2004, there have been
modest reductions in case notifications and significant
reductions in case notification rates (Table 1 and Figure 1).
This could be attributed to the focus on TB control in
Zambia over the last two decades and the implementation
of DOTS, which possibly increased the number of TB cases
reported in the first instance, followed by a reduction in the
number of reported TB cases because of reduced trans-
mission (Soltan et al. 2008). The rise in the number of
facilities in all districts led to more service delivery points.
Better financial support through sector-wide approaches
(SWAPS) provided grounds for sustaining consistent DOTS
implementation that consequently led to good treatment
success rates, reaching 86% in 2009. The increase in
financial resources to the programme through Global
Health Initiatives such as PEPFAR, GFATM and other
bilateral partners (DFID, CIDA-KNCV, TB CAP) may
have subsequently improved programme performance
through training and sensitization of health staff, more
community involvement and sensitization of the general
public leading to more people accessing TB services and a
subsequent increase in notified cases (National Tubercu-
losis Programme 2011). The exact impact of these invest-
ments by donors is difficult to assess.
The community groups and community volunteers who
try and ensure that patients with TB are supported and
take their medication contribute to improving treatment
outcomes that, over a sustained period, can contribute to
the declining trends (Mulenga et al. 2010a). The declining
trends cannot be attributed to the reduction in HIV
prevalence (14.3% in 2001 to 13.5% in 2009), which has
not dropped significantly (UNAIDS 2010).
More sputum smear-negative than smear-positive cases
are notified every year, and 75% of the smear-positive
cases are from the more urbanized areas such as Lusaka,
the Northern Copper Belt region and Southern Provinces,
which account for 40% of the total population (CSO
2011b). This is likely to be because there are more
microscopy diagnostic facilities and medical human
resources in urban than in rural provinces. Strengthening
the healthcare system in more rural areas would lead to
increased TB case detection and notification and govern-
ment and donor funding for this purpose must be made a
priority if TB is to be controlled in Zambia.
More male than female TB cases were notified to the
NTP every year during the period under review, which is in
contrast to the gender proportions in the general popula-
tion. Also, there are more females than males with
HIV ⁄AIDS in Zambia (UNAIDS 2010), which is a major
risk factor for susceptibility to TB (De Cock & Chaisson
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1999; Corbett et al. 2006; Lawn & Zumla 2011). The
reasons why men are more susceptible to TB than women
in Zambia need to be explored further. Nonetheless, this
gender disparity correlates with the global situation (WHO
2010a).
A greater percentage of TB cases are within the repro-
ductive age group. Therefore, many patients with TB will
either be pregnant or have young children. Current
Zambian TB data do not record the pregnancy status of
patients; hence, the burden of TB in pregnancy is poorly
understood and needs to be defined. TB is an important
cause of the maternal mortality from non-obstetric causes
(Ahmed et al. 1999; Grange et al. 2010); hence, there is an
urgent need to understand TB in pregnancy and intensify
diagnosis and safe treatment for TB in expecting mothers.
The TB burden in children in Zambia remains undefined
because of several reasons. TB is easily missed owing to
difficulties in making an accurate diagnosis of TB in
children and also owing to the problems in differentiating
TB from other childhood respiratory infections (Chintu
et al. 2002). Thus, childhood TB is not well documented
within the NTP. TB is difficult to diagnose in children,
especially in those under 5 years. The recent development
of the Xpert MTB ⁄RIF assay for the simultaneous detec-
tion of M. tuberculosis and rifampicin resistance is an
important advance that requires evaluation in childhood
TB (Nicol & Zar 2011), but because sputum is difficult to
obtain from young children, this test may not provide all
answers (Mwaba et al. 2011). More needs to be done to
address childhood TB. Hospital childhood TB programmes
should be separated from adult programmes, strengthened
and should work closely with the NTP.
Treatment success and cure rates have improved
significantly since 2000 in Zambia (Table 2). The treat-
ment outcomes reflect the improvements in TB control.
This may be an indication that the DOTS strategy has the
potential to reduce the TB burden when sustained over
time (Soltan et al. 2008). The high treatment success rates
have contributed to the declining notification rates and
may indicate that TB transmission in the general public
may be decreasing. Being a low-income country, Zambia
relies mainly on light microscopy for TB diagnostics,
which is notoriously insensitive (Steingart et al. 2006).
Current policies need to be improved upon if Zambia is
to achieve TB control. Active case finding is an additional
strategy for improving case detection rates as shown in
Zimbabwe (Corbett et al. 2006). Improved case detection
can be achieved using superior diagnostics. The recent
WHO endorsement of Xpert MTB ⁄RIF is an exciting
development but research must be performed on how to
appropriately implement such technology in Zambia.
Financing the implementation of expensive molecular
diagnostics technology for the rapid and accurate diag-
nosis of TB, and for detecting and defining the problem of
drug-resistant TB, is also a major issue (Mwaba et al.
2011). Sufficient infrastructure does not currently exist in
Zambia for the accurate diagnosis of drug-resistant TB
and for its surveillance. Thus, the epidemiology and
importance of drug-resistant TB in Zambia remains
relatively undefined.
Two-thirds of Zambian TB patients notified to the NTP
are co-infected with HIV (CDC 2008, WHO 2010a). It
thus becomes very important to align and integrate TB and
HIV services, so that more effective patient care can be
established. Antiretroviral drugs only became available in
Zambia in 2003 enabling HIV services in the public sector
to be established. Antiretroviral therapy (ART) roll-out
and HIV services are still lagging behind. There are now
close to 400 facilities in Zambia at which ART is offered
across the whole country with now approximately 400 000
people accessing ARVs. TB services, on the other hand, are
offered in all 1800 facilities in the country. TB and HIV
services are not yet integrated, although efforts are being
made to achieve this.
It is prudent that advances in new technology are
adopted and implemented into developing country
programmes, improving the quality and effectiveness of
TB services within their health systems. There should be
concurrent investments into improved case detection and
treatment for TB in children and other vulnerable groups
like pregnant women, prisoners, homeless and HIV-
infected people. This would contribute to the achievement
of millennium development goal 6 and also goals 4 and 5
that address reduction in infant mortality and maternal
mortality (UN 2010). Donors must focus their investments
towards strengthening health services in sub-Saharan
African countries to optimize TB and TB ⁄HIV care.
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